Newsroom
-
November 20 , 2023
FDA signs off on new uses for Astellas and Pfizer's Xtandi, Merck's Keytruda
Read more -
November 18 , 2023
AstraZeneca's first-in-class FDA approval for Truqap marred by surprise restriction
Read more -
November 17 , 2023
BeiGene Receives European Commission Approval for BRUKINSA® (zanubrutinib) for the Treatment of Relapsed or Refractory Follicular Lymphoma
Read more -
November 14 , 2023
Legend Biotech Announces Exclusive, Global License Agreement for Certain CAR-T Therapies Targeting DLL3
Read more -
November 9 , 2023
HUTCHMED Announces that Takeda Receives U.S. FDA Approval of FRUZAQLA™ (fruquintinib) for Previously Treated Metastatic Colorectal Cancer
Read more